Bumper Offer - Urjas oil Just @ Rs. 1
Rifaximax 200 Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Hepatic Encephalopathy. Secondary and off-label uses of Rifaximax 200 Tablet have also been mentioned below.
The correct dosage of Rifaximax 200 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Rifaximax 200 Tablet include Flatulence, Bloating or fullness, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rifaximax 200 Tablet as well, which are listed below. These side effects of Rifaximax 200 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Rifaximax 200 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Rifaximax 200 Tablet's effects on the liver, heart and kidney are discussed below in the Rifaximax 200 Tablet related warnings section.
Some other conditions that can be affected by Rifaximax 200 Tablet are listed in the contraindications section below.
Drug reaction of Rifaximax 200 Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Rifaximax 200 Tablet is safe while driving, and is is addictive in nature.
Rifaximax 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Is the use of Rifaximax 200 Tablet safe for pregnant women?
Rifaximax can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Rifaximax 200 Tablet safe during breastfeeding?
Rifaximax may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rifaximax 200 Tablet on the Kidneys?
Using Rifaximax does not have any harmful effects on kidneys.
What is the effect of Rifaximax 200 Tablet on the Liver?
Rifaximax may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rifaximax 200 Tablet on the Heart?
Rifaximax is not harmful for the heart.
Rifaximax 200 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rifaximax 200 Tablet unless your doctor advises you to do so -
Is this Rifaximax 200 Tablet habit forming or addictive?
Rifaximax 200 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rifaximax 200 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but take Rifaximax 200 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Rifaximax 200 Tablet is not used to treat mental disorders.
Interaction between Food and Rifaximax 200 Tablet
Taking Rifaximax 200 Tablet with food does not harm your health.
Interaction between Alcohol and Rifaximax 200 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rifaximax 200 Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
